& Laserson, U. MHC ﬂurry 2.0: Improved pan-allele prediction of MHC Class I-presented peptides by incorporating antigen proces-sing. Cell Syst. 11, 418 –419 (2020). 12. Hebeisen, M. et al. Identifying individual T cell receptors of optimal avidity for tumor antigens. Front. Immunol. 6, 582 (2015). 13. Campillo-Davo, D., Flumens, D. & Lion, E. The quest for the best: how TCR af ﬁnity, avidity, and functional avidity affect TCR-engineered T-cell antitumor responses.Cells 9, 1720 (2020). 14.